G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function
暂无分享,去创建一个
[1] Stefan Offermanns,et al. International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B) , 2011, Pharmacological Reviews.
[2] G. Milligan,et al. Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective α1b-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers , 2008, The Biochemical journal.
[3] L. Miller,et al. Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor. , 2008, Biochimica et biophysica acta.
[4] G. Milligan,et al. Morphine Desensitization, Internalization, and Down-Regulation of the μ Opioid Receptor Is Facilitated by Serotonin 5-Hydroxytryptamine2A Receptor Coactivation , 2008, Molecular Pharmacology.
[5] D. Nicholls,et al. Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2 , 2008, Molecular Pharmacology.
[6] I. D. de Esch,et al. Phenylalanine 169 in the Second Extracellular Loop of the Human Histamine H4 Receptor Is Responsible for the Difference in Agonist Binding between Human and Mouse H4 Receptors , 2008, Journal of Pharmacology and Experimental Therapeutics.
[7] R. Mamillapalli,et al. Switching of G-protein Usage by the Calcium-sensing Receptor Reverses Its Effect on Parathyroid Hormone-related Protein Secretion in Normal Versus Malignant Breast Cells* , 2008, Journal of Biological Chemistry.
[8] F. Ciruela,et al. Detection of higher‐order G protein‐coupled receptor oligomers by a combined BRET–BiFC technique , 2008, FEBS letters.
[9] Marta Filizola,et al. Dopamine D2 receptors form higher order oligomers at physiological expression levels , 2008, The EMBO journal.
[10] J. Mallol,et al. Novel pharmacological targets based on receptor heteromers , 2008, Brain Research Reviews.
[11] P. Spano,et al. Reciprocal Regulation of Dopamine D1 and D3 Receptor Function and Trafficking by Heterodimerization , 2008, Molecular Pharmacology.
[12] N. Tinel,et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization , 2008, Nature Methods.
[13] K. Eidne,et al. G protein-coupled receptor dimers: functional consequences, disease states and drug targets. , 2008, Pharmacology & therapeutics.
[14] Vsevolod V Gurevich,et al. How and why do GPCRs dimerize? , 2008, Trends in pharmacological sciences.
[15] S. Schiffmann,et al. An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. , 2008, Current pharmaceutical design.
[16] M. Bouvier,et al. Conformational Rearrangements and Signaling Cascades Involved in Ligand-Biased Mitogen-Activated Protein Kinase Signaling through the β1-Adrenergic Receptor , 2008, Molecular Pharmacology.
[17] Nagarajan Vaidehi,et al. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. , 2008, Biophysical journal.
[18] Wayne A Hendrickson,et al. Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor , 2008, EMBO reports.
[19] Graeme Milligan,et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis , 2008, Nature.
[20] G. Milligan. A day in the life of a G protein‐coupled receptor: the contribution to function of G protein‐coupled receptor dimerization , 2008, British journal of pharmacology.
[21] F. Ciruela,et al. G‐protein‐coupled receptor heteromers: function and ligand pharmacology , 2008, British journal of pharmacology.
[22] L. Hunyady,et al. Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions. , 2008, The Journal of endocrinology.
[23] G. Milligan,et al. CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2–DOP receptor heterodimer , 2008, The Biochemical journal.
[24] Krzysztof Palczewski,et al. Efficient Coupling of Transducin to Monomeric Rhodopsin in a Phospholipid Bilayer* , 2008, Journal of Biological Chemistry.
[25] K. Lorenz,et al. Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. , 2008, Nature chemical biology.
[26] Thomas Bäck,et al. GPCR NaVa database: natural variants in human G protein‐coupled receptors , 2008, Human mutation.
[27] G. Reiser,et al. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor. , 2008, The Biochemical journal.
[28] F. Ciruela,et al. Light resonance energy transfer-based methods in the study of G protein-coupled receptor oligomerization. , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.
[29] R. Maggio,et al. G protein‐coupled receptor oligomerization provides the framework for signal discrimination 1 , 2007, Journal of neurochemistry.
[30] G. Milligan,et al. Allosteric modulation of heterodimeric G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.
[31] K. Fuxe,et al. Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease , 2007 .
[32] L. Miller,et al. Transmembrane Segment IV Contributes a Functionally Important Interface for Oligomerization of the Class II G Protein-coupled Secretin Receptor* , 2007, Journal of Biological Chemistry.
[33] S. Mosolov,et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial , 2007, Nature Medicine.
[34] T. Kent,et al. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance. , 2007, Current opinion in drug discovery & development.
[35] Graeme Milligan,et al. Agonist occupancy of a single monomeric element is sufficient to cause internalization of the dimeric beta2-adrenoceptor. , 2007, Cellular signalling.
[36] M. Parmentier,et al. Allosteric properties of G protein-coupled receptor oligomers. , 2007, Pharmacology & therapeutics.
[37] P. Conn,et al. G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo , 2007, Pharmacological Reviews.
[38] A. Salahpour,et al. Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization , 2007, Nature Methods.
[39] Thomas Huber,et al. G protein-coupled receptors self-assemble in dynamics simulations of model bilayers. , 2007, Journal of the American Chemical Society.
[40] R. Eglen,et al. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening. , 2007, Assay and drug development technologies.
[41] Joseph Shiloach,et al. Dimerization of the class A G protein-coupled neurotensin receptor NTS1 alters G protein interaction , 2007, Proceedings of the National Academy of Sciences.
[42] K. Ressler,et al. Specificity of Olfactory Receptor Interactions with Other G Protein-coupled Receptors* , 2007, Journal of Biological Chemistry.
[43] V. Setola,et al. Modified Receptor Internalization upon Coexpression of 5-HT1B Receptor and 5-HT2B Receptors , 2007, Molecular Pharmacology.
[44] Richard N. Zare,et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.
[45] S. Rees,et al. Protean Agonism at the Dopamine D2 Receptor: (S)-3-(3-Hydroxyphenyl)-N-propylpiperidine Is an Agonist for Activation of Go1 but an Antagonist/Inverse Agonist for Gi1,Gi2, and Gi3 , 2007, Molecular Pharmacology.
[46] K. Minneman,et al. Heterodimerization and surface localization of G protein coupled receptors. , 2007, Biochemical pharmacology.
[47] Graeme Milligan,et al. The α1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and Function , 2007, Molecular Pharmacology.
[48] P. Insel,et al. Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets. , 2007, Biochimica et biophysica acta.
[49] Graeme Milligan,et al. G protein-coupled receptor dimerisation: molecular basis and relevance to function. , 2007, Biochimica et biophysica acta.
[50] S. Mazères,et al. Physical Association between Neuropeptide FF and μ-Opioid Receptors as a Possible Molecular Basis for Anti-opioid Activity* , 2007, Journal of Biological Chemistry.
[51] Michel Bouvier,et al. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers , 2007, Pharmacological Reviews.
[52] Stuart C. Sealfon,et al. Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior , 2007, Neuron.
[53] B. O'dowd,et al. D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum , 2007, Proceedings of the National Academy of Sciences.
[54] K. Fuxe,et al. Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease. , 2007, Movement disorders : official journal of the Movement Disorder Society.
[55] Graeme Milligan,et al. The specificity and molecular basis of α1-adrenoceptor and CXCR chemokine receptor dimerization , 2007, Journal of Molecular Neuroscience.
[56] H. Lother,et al. Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension , 2007, Journal of Molecular Neuroscience.
[57] G. Milligan,et al. BRET analysis of GPCR oligomerization: newer does not mean better , 2007, Nature Methods.
[58] G. Milligan,et al. Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function* , 2006, Journal of Biological Chemistry.
[59] K. Jacobson,et al. Computational prediction of homodimerization of the A3 adenosine receptor. , 2006, Journal of molecular graphics & modelling.
[60] Andrea Iaboni,et al. A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer , 2006, Nature Methods.
[61] C. Combs,et al. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions , 2006, Molecular Cancer Therapeutics.
[62] J. Mazurkiewicz,et al. Serotonin 5-HT2C Receptor Homodimer Biogenesis in the Endoplasmic Reticulum , 2006, Journal of Biological Chemistry.
[63] Graeme Milligan,et al. G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery. , 2006, Drug discovery today.
[64] Krzysztof Palczewski,et al. Structure of the rhodopsin dimer: a working model for G-protein-coupled receptors. , 2006, Current opinion in structural biology.
[65] K. L. Martinez,et al. FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[66] Marta Filizola,et al. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[67] P. Insel,et al. Genetic variation in G-protein-coupled receptors – consequences for G-protein-coupled receptors as drug targets , 2005, Expert opinion on therapeutic targets.
[68] David J. Daniels,et al. Interaction of Bivalent Ligand KDN21 with Heterodimeric δ-κ Opioid Receptors in Human Embryonic Kidney 293 Cells , 2005, Molecular Pharmacology.
[69] B. O'dowd,et al. D1 and D2 Dopamine Receptors Form Heterooligomers and Cointernalize after Selective Activation of Either Receptor , 2005, Molecular Pharmacology.
[70] Graeme Milligan,et al. The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities* , 2005, Journal of Biological Chemistry.
[71] K. Palczewski,et al. Diversifying the repertoire of G protein-coupled receptors through oligomerization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[72] Jamie Fong,et al. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[73] M. le Maire,et al. Monomeric G-protein-coupled receptor as a functional unit. , 2005, Biochemistry.
[74] Michel Bouvier,et al. Methods to monitor the quaternary structure of G protein‐coupled receptors , 2005, The FEBS journal.
[75] C. Hague,et al. Heterodimerization with β2-Adrenergic Receptors Promotes Surface Expression and Functional Activity of α1D-Adrenergic Receptors , 2005, Journal of Pharmacology and Experimental Therapeutics.
[76] A. Finazzi-Agro’,et al. The importance of being dimeric , 2004, The FEBS journal.
[77] C. Hague,et al. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. , 2005, The Journal of pharmacology and experimental therapeutics.
[78] David J. Daniels,et al. Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells. , 2005, Molecular pharmacology.
[79] Krzysztof Palczewski,et al. Oligomerization of G protein-coupled receptors: past, present, and future. , 2004, Biochemistry.
[80] J. Banères,et al. Cooperative Conformational Changes in a G-protein-coupled Receptor Dimer, the Leukotriene B4 Receptor BLT1* , 2004, Journal of Biological Chemistry.
[81] J. Matthews,et al. The power of two: protein dimerization in biology. , 2004, Trends in biochemical sciences.
[82] G. Milligan,et al. Multiple Interactions between Transmembrane Helices Generate the Oligomeric α1b-Adrenoceptor , 2004, Molecular Pharmacology.
[83] Graeme Milligan,et al. Domain Swapping in the Human Histamine H1 Receptor , 2004, Journal of Pharmacology and Experimental Therapeutics.
[84] K. Fuxe,et al. Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. , 2004, Analytical chemistry.
[85] K. Ressler,et al. Olfactory receptor surface expression is driven by association with the beta2-adrenergic receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[86] Jean-François Mercier,et al. Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting* , 2004, Journal of Biological Chemistry.
[87] J. W. Wells,et al. Oligomeric potential of the M2 muscarinic cholinergic receptor , 2004, Journal of neurochemistry.
[88] Graeme Milligan,et al. G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.
[89] C. Hague,et al. Cell Surface Expression of α1D-Adrenergic Receptors Is Controlled by Heterodimerization with α1B-Adrenergic Receptors* , 2004, Journal of Biological Chemistry.
[90] C. Hague,et al. Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors. , 2004, The Journal of biological chemistry.
[91] N. Ryba,et al. The Receptors for Mammalian Sweet and Umami Taste , 2003, Cell.
[92] H. Rockman,et al. Dual Inhibition of &bgr;-Adrenergic and Angiotensin II Receptors by a Single Antagonist: A Functional Role for Receptor–Receptor Interaction In Vivo , 2003, Circulation.
[93] J. Klco,et al. C5a Receptor Oligomerization , 2003, Journal of Biological Chemistry.
[94] B. O'dowd,et al. D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. , 2003, Biochemistry.
[95] Pierre Casellas,et al. Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor , 2003, Journal of Biological Chemistry.
[96] Joseph Parello,et al. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. , 2003, Journal of molecular biology.
[97] R. Lefkowitz,et al. Regulation of G protein-coupled receptor signaling by scaffold proteins. , 2002, Circulation research.
[98] B. O'dowd,et al. Oligomerization of opioid receptors: generation of novel signaling units. , 2002, Current opinion in pharmacology.
[99] G. Milligan,et al. Protein-protein interactions at G-protein-coupled receptors. , 2001, Trends in pharmacological sciences.
[100] H. Lother,et al. Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness , 2001, Nature Medicine.
[101] S. Rees,et al. Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.
[102] L. Devi,et al. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[103] Y. Jan,et al. A Trafficking Checkpoint Controls GABAB Receptor Heterodimerization , 2000, Neuron.
[104] Michel Bouvier,et al. Functional Significance of Oligomerization of G-protein-coupled Receptors , 2000, Trends in Endocrinology & Metabolism.
[105] S. Rees,et al. Chimaeric Gα proteins: their potential use in drug discovery , 1999 .
[106] S. Rees,et al. Chimaeric G alpha proteins: their potential use in drug discovery. , 1999, Trends in pharmacological sciences.
[107] Alan Wise,et al. Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.
[108] B. Borowsky,et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. , 1998, Nature.
[109] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[110] P. Seeman,et al. Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.
[111] Michel Bouvier,et al. A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.
[112] Pierre Corvol,et al. Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling , 1996, The Journal of Biological Chemistry.
[113] G. Barsh,et al. Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding. , 1992, Molecular pharmacology.